CD47 and neoplasm: A significantly superior tumor regression for CFUS relative to CRT-NP treated cells (n=5) was noted in the mice over 4-week, suggesting that CFUS directly prevented the CD47 counteraction of CRT expression in melanoma cells to improve the therapeutic response (Figure 1I).